Cellular Biology |
From the Cardiovascular Institute (L.L.C., B.L.M.), Loyola University Medical Center, Maywood, Ill, and the Departments of Pediatrics (E.A.S., B.B.K.) and Physiology (B.P.D., J.S.), University of Kentucky College of Medicine, Lexington, Ky.
Correspondence to Jonathan Satin, PhD, Department of Physiology, MS-508, University of Kentucky College of Medicine, Lexington, KY 40536-0298. E-mail jsatin1{at}pop.uky.edu
| Abstract |
|---|
|
|
|---|
1G, T-type
Ca2+ channel. Immunohistochemical
localization showed expression of
1G Ca2+
channels in E14 myocardium, and staining of isolated ventricular
myocytes revealed membrane localization of the
1G channels.
Dihydropyridine-resistant inward Ba2+ or
Ca2+ currents were present in all fetal
ventricular myocytes tested. Regardless of charge carrier, inward
current inactivated with sustained depolarization and mirrored
steady-state inactivation voltage dependence of the
1G channel
expressed in human embryonic kidney-293 cells.
Ni2+ blockade discriminates among T-type
Ca2+ channel isoforms and is a relatively
selective blocker of T-type channels over other cardiac plasma membrane
Ca2+ handling proteins. We demonstrate that
100 µmol/L Ni2+ partially blocked
1G
currents under physiological external Ca2+.
We conclude that
1G T-type Ca2+ channels
are functional in midgestational fetal
myocardium.
Key Words: calcium channel cardiac development low-voltage-activated Ca2+ channel
| Introduction |
|---|
|
|
|---|
L-type and T-type Ca2+ channels
are perhaps most clearly distinguished by their respective voltage
range of activation. L-type Ca2+ channels
activate only with strong depolarizations (
>-50 mV),
corresponding to the plateau of the action potential. In contrast,
T-type Ca2+ channels activate with weak
depolarizations (
>-80 mV). In fact, we recently demonstrated that
T-type Ca2+ channels activate at slightly
more negative potentials than even cardiac
Na+ channel
currents.4 This
low-voltage-activation range of T-type Ca2+
channels allows them to provide a substantial inward, depolarizing
current in the late phase of diastole. Thus it is likely that T-type
Ca2+ current contributes to the initiation
of the action potential upstroke in pacemaker
cells.5 6 7
Embryonic ventricular myocytes are capable of automatic
activity, in contrast to normal adult myocardium. Studies on embryonic
chick ventricular myocytes clearly show the expression of T-type
Ca2+
current8 9 ;
however, the literature from embryonic mouse heart is controversial.
Nuss and Marbán10 showed
substantial T-type Ca2+ channel expression,
but Davies et al11 were
unable to detect T-type current. The recent molecular identification of
T-type Ca2+
channels12 13
facilitates unequivocal detection of channel gene expression. The
1G
channel is encoded by the CaV3.1
gene,12 and there are 4
distinct splice variants in the domain III-IV connecting loop in
rodents and
humans.14 15 16
Our recent studies showed that mouse atrial tumor (AT-1) cells
functionally express
1G-d
(CaV3.1d).17
AT-1 cells have an excitability pattern that parallels embryonic
ventricular myocytes, suggesting that developing myocardium may also
express
1G channels.
We undertook the present study to evaluate the expression of
T-type Ca2+ channels in embryonic myocytes.
We show that the T-type Ca2+ channel splice
variant
1G-d is expressed in embryonic day 13 (E13) to E14.5 mouse
ventricle, and we present data consistent with the hypothesis that
Ca2+ entry via the T-type channel may
contribute to excitability in the developing
myocardium.
| Materials and Methods |
|---|
|
|
|---|
Molecular Characterization
Total E13 ventricular RNA was characterized by
reverse transcriptasepolymerase chain reaction (RT-PCR), as described
elsewhere.17
Immunostaining
Type-specific antibodies 2xG1 (anti-
1G) and 2xH1
(anti-
1H), prepared against peptides derived from the
1G and
1H T-type channel
sequences12 13
(for 2xG1: FVCQGEDTRNITNKSDCAEAS and 2xH1: YYCEGPDTRNISTKAQCRAAH),
were immunoaffinity-purified commercially (Bethyl Laboratories).
Monoclonal antibody MF 20 (Developmental Studies Hybridoma Bank,
University of Iowa) was used to stain myofibrils using a
rhodamine-conjugated secondary antibody (Molecular Probes). For
additional details, see the online data supplement available at
http://www.circresaha.org.
Electrophysiology
Digested tissue yielded a large fraction of single,
spontaneously beating cells in culture medium (DMEM with 10% FBS, 100
U/mL penicillin, and 100 mg/mL streptomycin). Cells were used within 48
hours of isolation. Cells in culture medium were rinsed with recording
buffer for T-type Ca2+ current (in mmol/L:
CsCl 140, CaCl2 2.5, HEPES 10, tetrodotoxin
[TTX] 0.036, nifedipine 0.001, and E-4031 0.005; pH 7.4). The pipette
contained 140 mmol/L CsCl, 5 mmol/L EGTA, and 5 mg ATP; pH 7.4). All
recordings were at room temperature (20°C to 22°C). Mean cell
capacitance was 9.1±1.6 pF, n=12. Additional details of recording and
data analysis can be found
elsewhere.17 18
An expanded Materials and Methods section can be found in an online data supplement available at http://www.circresaha.org.
| Results |
|---|
|
|
|---|
1G-d splice
variant, as shown previously for AT-1 cells
(Figure 1
|
The expression of mRNA does not always correlate with
protein expression. To confirm protein expression, we used antibodies
(2xG1 and 2xH1) to evaluate expression and localization of T-type
channels in embryonic heart.
Figure 2D
shows a sagittal section of ventricle with
vigorous staining for
1G. We also noted staining of vasculature and
atrial walls
(Figure 2B
). Preimmune controls
(Figures 2A
and 2C
) and anti-
1H antibodies did not stain
(not shown). The staining of
1G was blocked completely by 2xG1
peptideabsorbed antibody
(Figure 2E
), whereas 2xH1 peptide had no effect on 2xG1
staining
(Figure 2F
). To additionally control for antibody
specificity, 2xG1 clearly stained human embryonic kidney (HEK) cells
stable-transfected with
1G; in contrast, HEK cells expressing
1H
or untransfected HEK cells did not show 2xG1 staining (see the online
data supplement). We also stained isolated ventricular myocytes using
the 2xG1 antibody
(Figure 3
). Cells were costained with MF 20, a monoclonal
antibody to myosin heavy chain, to confirm their identity as myocytes
(Figure 3A
).
Figure 3B
shows the expected plasma membrane localization of
1G, a staining pattern distinct from the myofibrillar staining with
MF 20. Taken together, the RT-PCR and immunostaining results show that
embryonic ventricular myocardium expresses the
1G-d splice
variant.
|
|
We performed whole-cell mode patch-clamp recordings of
embryonic ventricular myocytes to evaluate
1G-d channel function. To
isolate T-type channel current from voltage-gated
Na+, L-type Ca2+,
and K+ currents, we bathed cells in
Na+-free bath containing 2.5 mmol/L
Ba2+, 30 µmol/L TTX, and 100 µmol/L
nifedipine.
Figure 4
shows representative recordings of T-type
Ca2+ current. Channel kinetics
(Figure 4A
) and the steady-state inactivation voltage
dependence are consistent with scoring this current as a T-type
Ca2+ channel current. The voltage dependence
of activation is depolarized-shifted (midpoint=-22 mV;
Figure 4B
), but this is a consistent trend observed for
voltage-gated Na+ and
Ca2+ channels in developing
myocardium.8 20
The presence of inactivating Ba2+ current in
100 µmol/L nifedipine
(Figures 4A
and 4C
) is unequivocal evidence that the current
is not through L-type Ca2+
channels.
|
We used Ni2+ blockade as an
indication of T-type isoform expression in fetal cardiomyocytes.
Ni2+, 200 µmol/L, blocks the
1G
Ca2+ channel current by
50%; in
contrast,
10 µmol/L Ni2+ is sufficient
for half-block of the
1H T-type Ca2+
current.21 In E12.5 to E14
ventricular myocytes, 100 µmol/L Ni2+
blocks T-type Ca2+ current by 38.3±5.8%
(Figure 4D
; n=3). Ni2+-blocked and
-unblocked currents have a comparable voltage dependence of
inactivation consistent with a uniform dihydropyridine (DHP)-resistant
channel population. On the basis of Ni2+
blockade and current kinetics coupled with the molecular identification
and immunohistochemical data
(Figures 1 through 3![]()
![]()
), we assign the T-type
Ca2+ current in embryonic ventricular
myocardium as an
1G-d current.
| Discussion |
|---|
|
|
|---|
1G, T-type Ca2+ channel. In this
study we demonstrate for the first time, to our knowledge, the
following observations: (1)
1G mRNA and protein are expressed in
developing fetal cardiac myocytes; (2)
1G is functionally expressed,
as evidenced by T-type Ca2+ currents in
E12.5 to E14 ventricular myocytes; and (3)
100 µmol/L
Ni2+ half-blocks this T-type
Ca2+ current. This report provides an
experimental foundation for the hypothesis that T-type
Ca2+ current, specifically
1G-d,
contributes to plasma membrane Ca2+ flux for
contraction in the developing myocardium.
Our observation that E12.5 to E14 ventricular myocytes
express robust T-type Ca2+ current is
controversial. Nuss and
Marbán10 showed that late
fetal and neonatal mouse myocytes express T-type
Ca2+ current
(IT),
but the only other study of murine E12 to E14 ventricle detected no
IT
expression.11 Recently,
Leranguer et al22 and
Pignier and Potreau23 showed
progressive reduction of DHP-resistant current from postnatal day 4
through adulthood. Under conditions of millimolar extracellular
Ca2+, it may be difficult to separate T-
from L-type Ca2+ channel current in
ventricular myocytes. Nuss and
Marbán10 showed the
presence of a 10 µmol/L nitrendipine-resistant
Ba2+ current in fetal cardiomyocytes.
Furthermore, this current inactivated with sustained depolarization and
as a function of steady-state holding potential. Similarly, we observed
a 100 µmol/L nifedipine-resistant inactivating
Ba2+ current. Furthermore, the steady-state
inactivation voltage dependence was similar to our steady-state
inactivation measurements of
1G expressed heterologously in HEK293
cells.4 17 We
increased the nifedipine dose to 100 µmol/L to completely block
L-type Ca2+
current24 25 and
exposed the cells to drug for >5 minutes to prevent confusion of
use-dependent blockade of L-type channels with
IT.26
Therefore, the inward Ca2+ or
Ba2+ current that we observe is
DHP-resistant, thereby excluding L-type channels. Furthermore, the
current we measure inactivates both by sustained depolarization and by
steady-state holding potential; these properties exclude the
unidentified current in fetal myocytes in the
1C knockout
mouse.27 Finally, the
activity of this current in the presence of 30 µmol/L TTX excludes a
contribution from
ICa,TTX.28
We also suggest that the novel fetal
ICa,fe29
is in fact
1G T-type current. Given that heterologously expressed
current through
1G is DHP
resistant30 and that kinetic
and steady-state inactivation properties from fetal ventricular
myocytes mirror our earlier studies of
1G current, we conclude that
fetal ventricular myocytes express functional T-type
Ca2+ current. This assignment is based on a
combination of the exclusion of known inward current carriers and
parallels the reported properties of heterologously expressed T-type
channel current.
One procedure common between the present study and the study
by Nuss and Marbán10 is
that spontaneously active cells were selected for study. Automatic
activity is a well-described property of neonatal ventricular
myocytes.31 32 We
find it interesting to note the ongoing correlation of T-type
Ca2+ channel expression with pacemaker cells
from
heart5 6 8
and noncardiac tissues.33
Furthermore, the
1G-d splice variant that we now identify in fetal
ventricular myocytes is the same splice variant that we previously
identified in the murine AT-1 cell
line.17 As with fetal
myocytes, AT-1 cells in culture fire spontaneous action
potentials.34 Finally, our
present studies and the study by Nuss and
Marbán10 corroborate
earlier findings from chick that
IT in
early embryonic development has a depolarizing shifted voltage
dependence of the macroscopic
I-V
curve.8 This creates an
overlap of T- and L-type Ca2+ currents in
the absence of DHP. In any case, our results unequivocally show that a
particular splice variant of T-type Ca2+
channels is expressed in E13 ventricle and is a likely pathway for
inward, DHP-resistant Ca2+
current.
There are 3 major plasma membrane transport mechanisms for
inward Ca2+ flux in fetal cardiomyocytes:
ICa,L,
IT, and
reverse-mode
Na+-Ca2+
exchange. Unequivocal assessment of the relative contribution of these
mechanisms is hindered by the lack of selective pharmacological agents.
Ni2+ is relatively selective for
IT
compared with
ICa,L
and Na+-Ca2+
exchange, but it may also have subtle effects, particularly on
ICa,L in
the range of 100 µmol/L used in this
study.35 Therefore, in the
absence of selective T-type channel blockers, establishment of a role
for T-type Ca2+ channels in developing
myocardium may ultimately require a combination of molecular genetic
approaches, including their complete ablation using knockout strategies
and overexpression of
1G-d in mouse
heart.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2.
Nattel S. Ionic
determinants of atrial fibrillation and calcium channel abnormalities:
cause, consequence, or innocent bystander?
Circ Res. 1999;85:473476.
3. Nattel S, Li D, Yue L. Basic mechanisms of atrial fibrillation: very new insights into very old ideas. Annu Rev Physiol. 2000;62:5177.[Medline] [Order article via Infotrieve]
4.
Zhang Y, Cribbs LL,
Satin J. Arachidonic acid modulation of
1H, a cloned human T-type
calcium channel. Am J Physiol Heart
Circ Physiol. 2000;278:184193.
5.
Huser J, Blatter
LA, Lipsius SL. Intracellular Ca2+ release
contributes to automaticity in cat atrial pacemaker cells.
J Physiol (Lond). 2000;524:415422.
6. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol. 1988;395:223253.
7. Lei M, Brown H, Noble D. What role do T-type calcium channels play in cardiac pacemaker activity? In: Tsien RW, Clozel J-P, Nargeot J, eds. Low Voltage-Activated T-type Calcium Channels. Chester, UK: Adis International; 1996:103109.
8. Kawano S, Dehaan RL. Developmental changes in the calcium currents in embryonic chick ventricular myocytes. J Membr Biol. 1991;120:1728.[Medline] [Order article via Infotrieve]
9. Brotto MA, Creazzo TL. Ca2+ Transients in embryonic chick heart: contributions from Ca2+ channels and the sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol. 1996;270:518525.
10.
Nuss HB, Marbán
E. Electrophysiological properties of neonatal mouse cardiac myocytes
in primary culture. J
Physiol. 1994;479:265279.
11.
Davies MP, An RH,
Doevendans P, Kubalak S, Chien KR, Kass RS. Developmental changes in
ionic channel activity in the embryonic murine heart.
Circ Res. 1996;78:1525.
12. Perez-Reyes E, Cribbs LL, Daud A, Lacerda AE, Barclay J, Williamson MP, Fox M, Rees M, Lee J-H. Molecular characterization of a neuronal low-voltage activated T-type calcium channel. Nature. 1998;391:896900.[Medline] [Order article via Infotrieve]
13.
Cribbs LL, Lee
J-H, Yang J, Satin J, Zhang Y, Daud A, Barclay J, Williamson MP, Fox M,
Rees M, Perez-Reyes E. Cloning and characterization of
1H from human
heart, a member of the T-type calcium channel gene family.
Circ Res. 1998;83:103109.
14.
Lee JH, Daud AN,
Cribbs LL, Lacerda AE, Pereverzev A, Klockner U, Schneider T,
Perez-Reyes E. Cloning and expression of a novel member of the low
voltage-activated T-type calcium channel family.
J Neurosci. 1999;19:19121921.
15.
Monteil A, Chemin
J, Bourinet E, Nargeot J, Lory P. Identification of multiple human
1G isoforms of T-type calcium channels with distinct functional
properties. Biophys J. 2000;78:199a. Abstract.
16. Cribbs LL, Gomora JC, Daud AN, Lee JH, Perez-Reyes E. Molecular cloning and functional expression of CaV3.1c, a T-type calcium channel from human brain. FEBS Lett.. 2000;466:5458.[Medline] [Order article via Infotrieve]
17.
Satin J, Cribbs
LL. Identification of a T-type calcium channel isoform in murine atrial
myocytes (AT-1). Circ Res. 2000;86:636642.
18. Delisle BP, Satin J. pH Modification of human T-type calcium channel gating. Biophys J.2000;78:18951905.
19.
Lambert RC,
McKenna F, Maulet Y, Talley EM, Bayliss DA, Cribbs LL, Lee J-H,
Perez-Reyes E, Feltz A. Low-voltage-activated
Ca2+ currents are generated by members of
the CaVT subunit family (
1G/H) in rat primary
sensory neurons. J
Neurosci. 1998;18:86058613.
20. Fujii S, Ayer RK Jr, DeHaan RL. Development of the fast sodium current in early embryonic chick heart cells. J Membr Biol. 1988;101:209223.[Medline] [Order article via Infotrieve]
21.
Lee J-H, Gomora
JC, Cribbs LL, Perez-Reyes E. Nickel block of three cloned T-type
calcium channels: low concentrations selectively block
1H.
Biophys J. 1999;77:30343042.[Medline]
[Order article via Infotrieve]
22.
Leuranguer V,
Monteil A, Bourinet E, Dayanithi G, Nargeot J. T-type calcium currents
in rat cardiomyocytes during postnatal development: contribution to
hormone secretion. Am J Physiol Heart
Circ Physiol. 2000;279:H2540H2548.
23.
Pignier C,
Potreau D. Characterization of nifedipine-resistant calcium current in
neonatal rat ventricular cardiomyocytes.
Am J Physiol Heart Circ
Physiol. 2000;279:H2259H2268.
24.
Wasserstrom
JA, Vites AM. The role of
Na+-Ca2+ exchange
in activation of excitation-contraction coupling in rat heart cells.
J Physiol. 1996;493:529542.
25.
Shen J-B, Jiang
B, Pappano AJ. Comparison of L-Type calcium channel blockade by
nifedipine and/or cadmium in guinea-pig ventricular myocytes.
J Pharmacol Exp Ther. 2000;294:562570.
26.
Mery P-F,
Hove-Madsen L, Mazet J-L, Hanf R, Fischmeister R. Binding constants
determined from Ca2+ current responses to
rapid applications and washouts of nifedipine in frog cardiac myocytes.
J Physiol. 1996;494:105120.
27.
Seisenberger C,
Specht V, Welling A, Platzer J, Pfeifer A, Kuhbandner S, Striessnig J,
Klugbauer N, Feil R, Hofmann F. Functional embryonic cardiomyocytes
after disruption of the L-type
1C (CaV1.2)
calcium channel gene in the mouse. J
Biol Chem. 2000;275:3919339199.
28.
Aggarwal R,
Shorofsky SR, Goldman L, Balke CW. Tetrodotoxin-blockable calcium
currents in rat ventricular myocytes: a third type of cardiac cell
sodium current. J Physiol. 1997;505:353369.
29.
Tohse N, Masuda
H, Sperelakis N. Novel isoform of Ca2+
channel in rat fetal cardiomyocytes.
J Physiol. 1992;451:295306.
30.
Lacinova L,
Klugbauer N, Hofmann F. Regulation of the calcium channel
1G subunit
by divalent cations and organic blockers.
Neuropharmacology. 2000;39:12541266.[Medline]
[Order article via Infotrieve]
31.
Kamino K. Optical
approaches to ontogeny of electrical activity and related functional
organization during early heart development.
Physiol Rev. 1991;71:5391.
32. DeHaan RL. Differentiation of excitable membranes. Curr Topics Dev Biol. 1980;16:117164.[Medline] [Order article via Infotrieve]
33. Huegenard JR. Low-threshold calcium currents in central nervous system neurons. Annu Rev Physiol. 1996;58:329348.[Medline] [Order article via Infotrieve]
34.
Yang T, Wathen
MS, Felipe A, Tamkun MM, Snyders DJ, Roden DM.
K+ currents and
K+ channel mRNA in cultured atrial cardiac
myocytes (AT-1 Cells). Circ
Res. 1994;75:870878.
35. Hobai IA, Hancox JC, Levi AJ. Inhibition by nickel of the L-type Ca2+ channel in guinea pig ventricular myocytes and effect of internal cAMP. Am J Physiol Heart Circ Physiol. 2000;279:692701.
This article has been cited by other articles:
![]() |
E. Schroder, M. Byse, and J. Satin L-Type Calcium Channel C Terminus Autoregulates Transcription Circ. Res., June 19, 2009; 104(12): 1373 - 1381. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-S. Chiang, C.-H. Huang, H. Chieng, Y.-T. Chang, D. Chang, J.-J. Chen, Y.-C. Chen, Y.-H. Chen, H.-S. Shin, K. P. Campbell, et al. The CaV3.2 T-Type Ca2+ Channel Is Required for Pressure Overload-Induced Cardiac Hypertrophy in Mice Circ. Res., February 27, 2009; 104(4): 522 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Jaleel, H. Nakayama, X. Chen, H. Kubo, S. MacDonnell, H. Zhang, R. Berretta, J. Robbins, L. Cribbs, J. D. Molkentin, et al. Ca2+ Influx Through T- and L-Type Ca2+ Channels Have Different Effects on Myocyte Contractility and Induce Unique Cardiac Phenotypes Circ. Res., November 7, 2008; 103(10): 1109 - 1119. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Q. Zhang and K. D. Sarge Sumoylation regulates lamin A function and is lost in lamin A mutants associated with familial cardiomyopathies J. Cell Biol., October 23, 2008; 182(1): 35 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Rapila, T. Korhonen, and P. Tavi Excitation-Contraction Coupling of the Mouse Embryonic Cardiomyocyte J. Gen. Physiol., September 29, 2008; 132(4): 397 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Korhonen, R. Rapila, and P. Tavi Mathematical Model of Mouse Embryonic Cardiomyocyte Excitation-Contraction Coupling J. Gen. Physiol., September 29, 2008; 132(4): 407 - 419. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Mangoni and J. Nargeot Genesis and Regulation of the Heart Automaticity Physiol Rev, July 1, 2008; 88(3): 919 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sun, D. Varela, D. Chartier, P. C. Ruben, S. Nattel, G. W. Zamponi, and N. Leblanc Differential Interactions of Na+ Channel Toxins with T-type Ca2+ Channels J. Gen. Physiol., July 1, 2008; 132(1): 101 - 113. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J. Wang and E. A. Sobie Mathematical model of the neonatal mouse ventricular action potential Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2565 - H2575. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Kapur and K. Banach Inositol-1,4,5-trisphosphate-mediated spontaneous activity in mouse embryonic stem cell-derived cardiomyocytes J. Physiol., June 15, 2007; 581(3): 1113 - 1127. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Crump, R. N. Correll, E. A. Schroder, W. C. Lester, B. S. Finlin, D. A. Andres, and J. Satin L-type calcium channel {alpha}-subunit and protein kinase inhibitors modulate Rem-mediated regulation of current Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1959 - H1971. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Laleve, M. C. Rebsamen, S. Barrere-Lemaire, E. Perrier, J. Nargeot, J.-P. Benitah, and M. F. Rossier Aldosterone increases T-type calcium channel expression and in vitro beating frequency in neonatal rat cardiomyocytes Cardiovasc Res, August 1, 2005; 67(2): 216 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. I. Brueggemann, B. L. Martin, J. Barakat, K. L. Byron, and L. L. Cribbs Low voltage-activated calcium channels in vascular smooth muscle: T-type channels and AVP-stimulated calcium spiking Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H923 - H935. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Niwa, K. Yasui, T. Opthof, H. Takemura, A. Shimizu, M. Horiba, J.-K. Lee, H. Honjo, K. Kamiya, and I. Kodama Cav3.2 subunit underlies the functional T-type Ca2+ channel in murine hearts during the embryonic period Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2257 - H2263. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ferron, V. Capuano, Y. Ruchon, E. Deroubaix, A. Coulombe, and J.-F. Renaud Angiotensin II Signaling Pathways Mediate Expression of Cardiac T-Type Calcium Channels Circ. Res., December 12, 2003; 93(12): 1241 - 1248. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. M. Zhang, L. Shang, C. Hartzell, M. Narlow, L. Cribbs, and S. C. Dudley Jr. Characterization and regulation of T-type Ca2+ channels in embryonic stem cell-derived cardiomyocytes Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2770 - H2779. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Xu, A. Welling, S. Paparisto, F. Hofmann, and N. Klugbauer Enhanced Expression of L-type Cav1.3 Calcium Channels in Murine Embryonic Hearts from Cav1.2-deficient Mice J. Biol. Chem., October 17, 2003; 278(42): 40837 - 40841. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A.G. van der Heyden, M. J.A. van Kempen, Y. Tsuji, M. B. Rook, H. J. Jongsma, and T. Opthof P19 embryonal carcinoma cells: a suitable model system for cardiac electrophysiological differentiation at the molecular and functional level Cardiovasc Res, May 1, 2003; 58(2): 410 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Perez-Reyes Molecular Physiology of Low-Voltage-Activated T-type Calcium Channels Physiol Rev, January 1, 2003; 83(1): 117 - 161. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |